Exelixis registers Phase 2 trial pairing zanzalintinib with pembrolizumab in NSCLCSep 29Trial updateExelixispembrolizumab
Exelixis registers Phase 1 pediatric trial of zanzalintinib in solid tumorsAug 19Trial updateExelixiszanzalintinib
Exelixis registers Phase 3 STELLAR-316 trial of zanzalintinib in colorectal cancer MRDAug 6Trial updateExelixisMerck & Co., Inc.
Exelixis Q2 2026 results detail zanzalintinib pipeline progress, narrows guidanceAug 5Quarterly updateExelixisMerck & Co., Inc.
Dana-Farber registers Phase 2 zanzalintinib trial for rare adrenal tumors, Exelixis collaboratingJul 20Trial updateExelixiszanzalintinib
Sign inSign in